Prevalence of Potential Drugs


The main purpose of this study is to evaluate the prevalence and explain the characteristics of PDDIs  in medical recommendation of hospitalized surgical patients. In this transverse study, we examine 370 medical prescriptions from the surgery unit of a Mexican public teaching hospital. The classification and identification of potential drug-drug interactions were performed with the Micromedex 2.0 electronic drug information database. Results were examined with illustrative statistics and we estimated OR (odds ratio) to determine associated risk factors.




 


  • Study of Medscape Drug Interaction Checker

Related Conference of Prevalence of Potential Drugs

September 14-15, 2026

6th International Conference on Pharmaceutical Chemistry

Paris, France
September 24-25, 2026

6th World Congress on Rare Diseases & Orphan Drugs

Paris, France
November 26-27, 2026

5th World Congress on Precision and Personalized Medicine

Zurich, Switzerland
November 26-27, 2026

5th World Conference on Pharma Industry and Medical Devices

Zurich, Switzerland
December 14-15, 2026

5th Global Summit on Pharmaceutical Research

Paris, France
January 26-27, 2027

22nd Annual Meet on Pharmaceutical Sciences

Paris, France
February 15-16, 2027

23rd Annual Congress on Pharmacology and Toxicology

Paris, France
February 22-23, 2027

41st World Congress on Pharmacology and Therapeutics

Amsterdam, Netherlands
April 08-09, 2027

21st World Drug Delivery Summit

Vienna, Austria
April 27-28, 2027

19th World Drug Delivery Summit

Paris, France
April 27-28, 2027

10th European Biopharma Congress

Paris, France

Prevalence of Potential Drugs Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in